RGEN Q1 2024 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$153M-7.4% YoY

Gross Profit

$77M50.1% margin

Operating Income

$4M2.4% margin

Net Income

$3M2.2% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$36M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$879M

Stockholders' Equity

$2.0B

Cash & Equivalents

$781M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$153M	$165M	-7.4%
Gross Profit	$77M	$84M	-8.1%
Operating Income	$4M	$14M	-72.9%
Net Income	$3M	$15M	-78.5%

Revenue Segments

Product

$151M100%

Royalty

$36,0000%